Why it may matterVerify against the original reporting
The NYSE listing elevates branding, liquidity, and market access. Non-GAAP metrics show meaningful profitability leverage (adjusted EBITDA 36% of revenue) despite GAAP losses from Harvest. A $50m buyback and Georgia/Florida expansion are near-term catalysts, while the Harvest deconsolidation, though depressing GAAP results, reduces future overhang and improves cash-flow visibility. Historically, such mix of cash-flow strength plus capital-market catalysts tends to support a short- to mid-term re-rating in small-cap cannabis names.
AI summary
What happened, with direct paths to the underlying reporting
Trulieve reported Q2 2026 revenue of $271 million with a 60% gross margin and $98 million in adjusted EBITDA (36% of revenue). GAAP net loss was $406 million due largely to Harvest deconsolidation, though adjusted net income was $20 million. The company secured an NYSE listing (ticker TRLV), announced a $50 million share repurchase, and expanded Georgia and Florida operations, supporting near-term upside despite one-off GAAP hits.
Q2 2026 revenue was $271 million with 60% gross margin.
Harvest deconsolidation completed June 3, 2026; GAAP loss inflated by $407m.
Trulieve listed on NYSE under TRLV; share repurchase up to $50m.
Adjusted EBITDA $98m (36% of revenue); adjusted net income $20m.
Georgia expansion and Florida store openings; 207 retail dispensaries, 3.5m sq ft capacity.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
